Work

Phase 2 Trial of Induction Gemcitabine, Oxaliplatin, and Cetuximab Followed by Selective Capecitabine-Based Chemoradiation in Patients With Borderline Resectable or Unresectable Locally Advanced Pancreatic Cancer

Year: 2014

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2013.12.030

Authors: Nestor F. Esnaola, Uzair B. Chaudhary, Paul O'Brien, Elizabeth Garrett-Mayer, E. Ramsay Camp, Melanie B. Thomas, David J. Cole, Alberto J. Montero, Brenda J. Hoffman, Joseph Romagnuolo, Kelly P. Orwat, David T. Marshall

Institutions: Medical University of South Carolina, MUSC Hollings Cancer Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: Medical University of South Carolina - Cancer Center Support Grant

OpenAlex ID: W2013100653

FWCI: 3.604

Cites: 18

Cited by: 49

Related to: 10